AN2 TherapeuticsANTX
13F holders, Q1 2024 (March 31)54holders
2famous investors
$3.25avg. 13F price*
At the end of Q1 2024, 54 institutions reported holding AN2 Therapeutics Inc. (ANTX) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($18.0M), Citadel Advisors ($5.1M) and TCG Crossover Management, LLC ($5.1M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- AN2 Therapeutics Inc.
- CUSIP
- 037326105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 18 | $3.1M |
| Exits | 15 | $15.0M |
Ownership 54 holders
| Ra Capital Management, L.P. | 0.23% | No change | 5,551,295 | $18.0M |
| Citadel Advisors | 0.01% | Reduce -0.0% | 1,556,554 | $5.1M |
| TCG Crossover Management, LLC | 0.40% | Reduce -41.9% | 1,555,118 | $5.1M |
| Frazier Life Sciences Management, L.P. | 0.19% | No change | 1,388,889 | $4.5M |
| BVF Inc. | 0.11% | Reduce -20.8% | 1,239,470 | $4.0M |
| Janus Henderson Group PLC | 0.00% | Reduce -4.6% | 1,221,145 | $4.0M |
| Avidity Partners Management LP | 0.13% | Add +0.9% | 1,150,000 | $3.7M |
| Octagon Capital Advisors LP | 0.44% | Add +66.0% | 1,103,000 | $3.6M |
| Vanguard Group Inc. | 0.00% | Reduce -0.5% | 1,047,769 | $3.4M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | Reduce -65.3% | 312,615 | $1.0M |
| BlackRock Inc. | 0.00% | Reduce -4.8% | 291,086 | $946K |
| Ghost Tree Capital, LLC | 0.23% | New | 219,331 | $713K |
| Susquehanna International Group, LLP | 0.00% | Add +104.1% | 202,850 | $659K |
| Geode Capital Management, LLC | 0.00% | Add +0.4% | 179,370 | $583K |
| Acadian Asset Management LLC | 0.00% | New | 163,496 | $529K |
| Walleye Capital LLC | 0.01% | New | 132,787 | $432K |
| Alyeska Investment Group, L.P. | 0.00% | Add +100.0% | 100,000 | $325K |
| Nantahala Capital Management, LLC | 0.03% | Reduce -60.4% | 98,278 | $319K |
| Millennium Management | 0.00% | Add +144.3% | 96,914 | $315K |
| Two Sigma Investments, LP | 0.00% | Add +389.2% | 94,168 | $306K |
| Marshall Wace, LLP | 0.00% | Reduce -75.5% | 82,498 | $268K |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | New | 76,200 | $248K |
| Citigroup Inc. | 0.00% | Reduce -55.9% | 70,807 | $230K |
| State Street Corp. | 0.00% | Add +57.4% | 60,302 | $196K |
| Jane Street Group, LLC | 0.00% | Reduce -0.5% | 59,166 | $192K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -30.3% | 50,365 | $164K |
| Squarepoint Ops LLC | 0.00% | New | 49,607 | $161K |
| Curi Capital, LLC | 0.00% | No change | 45,942 | $149K |
| Laurion Capital Management LP | 0.00% | No change | 43,814 | $142K |
| Prelude Capital Management, LLC | 0.01% | New | 40,300 | $131K |
| XTX Topco Ltd | 0.02% | New | 38,666 | $126K |
| Dimensional Fund Advisors LP | 0.00% | New | 38,115 | $124K |
| Occudo Quantitative Strategies LP | 0.02% | New | 37,697 | $123K |
| Northern Trust Corp. | 0.00% | Add +10.0% | 36,363 | $118K |
| Captrust Financial Advisors | 0.00% | No change | 28,667 | $93K |
| Goldman Sachs Group Inc. | 0.00% | Add +102.0% | 28,370 | $92K |
| Barclays PLC | 0.00% | Reduce -36.0% | 28,318 | $92K |
| Credit Suisse AG/ | 0.00% | New | 26,630 | $87K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -28.9% | 26,292 | $85K |
| HRT Financial LP | 0.00% | New | 24,366 | $79K |
| Private Advisor Group, LLC | 0.00% | New | 22,500 | $73K |
| Swiss National Bank | 0.00% | New | 20,575 | $67K |
| UBS Group AG | 0.00% | New | 19,574 | $64K |
| Chicago Partners Investment Group LLC | 0.00% | New | 22,001 | $52K |
| Bank of America Corp. | 0.00% | Reduce -31.6% | 14,972 | $49K |
| Atom Investors LP | 0.00% | New | 11,905 | $39K |
| Summit Securities Group LLC | 0.02% | New | 10,000 | $33K |
| California State Teachers Retirement System | 0.00% | New | 9,251 | $30K |
| Morgan Stanley | 0.00% | Add +25.0% | 4,164 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1666.7% | 1,113 | $4K |
| Osaic Holdings, Inc. | 0.00% | No change | 300 | $975 |
| Rhumbline Advisers | 0.00% | No change | 250 | $812 |
| Federated Hermes, Inc. | 0.00% | Reduce -18.2% | 211 | $686 |
| Wells Fargo & Company | 0.00% | Add +1.6% | 128 | $416 |
"% of holder's portfolio" is ANTX's weight in each manager's 13F, not the share of AN2 Therapeutics Inc. the manager owns.